Standard expected years of life lost (SEYLL) due to chronic obstructive pulmonary disease (COPD) in Poland from 1999 to 2014

Dziankowska-Zaborszczyk, Elżbieta; Bryła, Marek; Ciabiada-Bryła, Beata; Maniecka-Bryła, Irena

doi:10.1371/journal.pone.0213581

Cited by 8 publications

(18 citation statements)

References 38 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to previous literature, lung cancer and COPD are comparable in terms of average YLL and average PYLL, so we expect to find similar results in those measures [ 6 , 7 ]. Due to an expected larger number of patients diagnosed with COPD compared with lung cancer, the total YLL, total PYLL, and total productivity loss will be highest in the COPD group.…”

Section: Discussionsupporting

confidence: 54%

“…COPD has also been shown to account for 1.8% of all deaths in Poland between 1999 and 2014. In addition, the typical patient with COPD lost roughly 14.5 years of life due to the disease [ 7 ]. The authors concluded that since smoking remains the leading cause of COPD, public education on the risks of smoking could have a considerable effect on reducing the burden of COPD in Poland [ 7 ].…”

Section: Introductionmentioning

confidence: 99%

“…In addition, the typical patient with COPD lost roughly 14.5 years of life due to the disease [ 7 ]. The authors concluded that since smoking remains the leading cause of COPD, public education on the risks of smoking could have a considerable effect on reducing the burden of COPD in Poland [ 7 ]. A study examining mortality trends in Ontarians with COPD from 1996 to 2012 found that PYLL due to COPD decreased over the period, while COPD prevalence increased.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Economic Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer Between 2000 and 2015 in Saskatchewan: Study Protocol

Penz¹,

Fenton²,

Hu³

et al. 2022

JMIR Res Protoc

View full text Add to dashboard Cite

Background Chronic obstructive pulmonary disease (COPD) and lung cancer are both detrimental diseases that present great burdens on society. Years of life lost (YLL), premature years of life lost (PYLL), working years lost (WYL), and productivity loss are all effective measures in identifying economic burden of disease. Objective We propose a population-based study to analyze comprehensive provincial cohorts of Saskatchewan residents with COPD, lung cancer, and combined COPD and lung cancer in order to identify the burden these diseases present. Methods Saskatchewan residents over the age of 35 years who had COPD, lung cancer, or both, between January 1, 2000, and December 31, 2015, will be identified and used in this study. Data for analysis including age, gender, and date of death, alongside Statistics Canada income estimates, will be used to estimate productivity loss and WYL. Statistics Canada life tables will be used to calculate YLL and PYLL by subtracting the patients’ ages at death by their life expectancies, adjusted using sex and age at death. We will link the Saskatchewan cancer registry with Saskatchewan health administrative databases to create three cohorts: (1) COPD; (2) lung cancer; and (3) COPD and lung cancer. Individuals with lung cancer will be identified using ICDO-T (International Classification of Diseases for Oncology-Topography) codes, and those with COPD will be defined and identified as individuals who had at least 1 visit to a physician with a diagnosis of COPD or 1 hospital separation with a diagnosis of COPD. Those without a valid health care coverage for a consecutive 12 months prior to the first diagnostic code will be excluded from the study. Those with a combined diagnosis of COPD and lung cancer will be identified as individuals who were diagnosed with COPD in the 12 months following their lung cancer diagnosis or anytime preceding their lung cancer diagnosis. Results As of April 2021, we have had access to all relevant data for this study, have received funding (January 2020), and have begun the preliminary analysis of our data set. Conclusions It is well documented that COPD and lung cancer are both destructive diseases in terms of YLL, PYLL, WYL, and productivity loss; however, no studies have been conducted to analyze a cohort with combined COPD and lung cancer. Understanding the economic burden associated with each of our 3 cohorts is necessary in understanding and thus reducing the societal impact of COPD and lung cancer. International Registered Report Identifier (IRRID) RR1-10.2196/31350

show abstract

Section: Discussionsupporting

confidence: 54%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Economic Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer Between 2000 and 2015 in Saskatchewan: Study Protocol

Penz¹,

Fenton²,

Hu³

et al. 2022

JMIR Res Protoc

View full text Add to dashboard Cite

show abstract

“…The SEYLL approach has been used by most of the studies about the burden of the disease up to now [1,7,8], but to the best of our knowledge, previous studies have neglected or had not estimated the burden of premature mortality for Middle East respiratory syndrome coronavirus (MERS-CoV) infection. In the last decade, we have seen the emergence of coronaviruses, which are responsible for acute respiratory infections with a high mortality rate [9].…”

Section: Introductionmentioning

confidence: 99%

The global burden of premature mortality due to the Middle East respiratory syndrome (MERS) using standard expected years of life lost, 2012 to 2019

et al. 2019

View full text Add to dashboard Cite

BackgroundIt has been 8 years since the first case of Middle East respiratory syndrome coronavirus (MERS-CoV) was reported in Saudi Arabia and the disease is still being reported in 27 countries; however, there is no international study to estimate the overall burden related of this emerging infectious disease. The present study was conducted to assess the burden of premature mortality due to Middle East respiratory syndrome (MERS) worldwide.MethodsIn this retrospective analysis, we have utilized publicly available data from the WHO website related to 1789 MERS patients reported between September 23, 2012 and May 17, 2019. To calculate the standard expected years of life lost (SEYLL), life expectancy at birth was set according to the 2000 global burden of disease study on levels 25 and 26 of West model life tables from Coale-Demeny at 82.5 and 80 years for females and males, respectively.ResultsOverall, the total SEYLL in males and females was 10,702 and 3817.5 years, respectively. The MERS patients within the age range of 30–59 year-olds had the highest SEYLL (8305.5 years) in comparison to the patients within the age groups 0–29 (SEYLL = 3744.5 years) and ≥ 60 years (SEYLL = 2466.5 years). The total SEYLL in all age groups in 2012, 2013, 2014, 2015, 2016, 2017, 2018, and 2019 were 71.5, 2006.5, 3162, 4425.5, 1809.5, 878, 1257.5 and 909 years, respectively. The most SEYLL related to MERS-CoV infection was in the early four years of the onset of the pandemic (2012 to 2015) and in the last four years of the MERS-CoV pandemic (216 to 2019), a significant reduction was observed in the SEYLL related to MERS-CoV infection in the MERS patients.ConclusionWe believe that the findings of this study will shed light about the burden of premature mortality due to MERS infection in the world and the results may provide necessary information for policy-makers to prevent, control, and make a quick response to the outbreak of MERS-CoV disease.

show abstract

“…We also observed that the diagnosis delay for outpatients living in rural areas was signi cantly higher than that in cities. Several recent studies 24,25,26,27 around the world revealed the greatest decrease in the analyzed measures of the standard expected years of life lost due to COPD was observed among males from rural areas in Poland (p<0.05) (SEYLL: AAPC = -1.6) and COPD patients living in rural areas of Mexico were more likely to be Biomass smoke exposure (47%) and had a higher prevalence. Besides that multivariate logistic regression indicated that lower educational levels and poor access to medical services was associated with an overall higher risk of COPD as well as a lower probability of COPD (P = 0.002) in rural Southwest China.…”

Section: Discussionmentioning

confidence: 99%

Analysis of Medical Seeking Behavior and Influencing Factors in Patients With Chronic Obstructive Pulmonary Disease

Dai

Zhan

Chen

et al. 2021

Preprint

View full text Add to dashboard Cite

Purpose: To explore the status of medical seeking behavior in patients with chronic obstructive pulmonary disease (COPD), and clarify relevant factors that may affect the diagnosis delay. Methods: A cross-sectional study was conducted in a Chinese tertiary hospital from July 2019 to February 2020. A total of 408 eligible outpatient COPD patients were recruited and relevant data were collected in the form of questionnaire. Diagnosis delay was compared among different characteristics using Wilcoxon test and Kruskal-Wallis H test. Correlation analysis were performed to further explore factors related to diagnosis delay. Results: The median (interquartile range [IQR]) duration of diagnosis delay was 230 (50 - 720) days. Proportions of COPD patients who chose tertiary hospitals, secondary hospitals, and first – level hospitals for the first visit were respectively 53.7%, 29.9% and 16.4%. Additionally, proportions of patients who received pulmonary function test for the first visit in tertiary hospitals, secondary hospitals, and first – level hospitals were namely, 83.9%, 15.5%, and 1.5% (p < 0.001). In terms of characteristics related to diagnosis delay, there is a significant difference in residence, resident manner, CAT , mMRC, age, FEV1% predicted, years of education, average family income(p < 0.001). Furthermore, diagnosis delay is correlated with patients’ knowledge level of COPD and other characteristic variables (including age, years of education, resident manner, average family income, CAT , mMRC, FEV1% predicted, and FEV1/FVC) to varying degrees. Conclusion: Our study indicates that varying degrees of diagnosis delay may exist in COPD patients. Measures are needed to intervene potential factors related to diagnosis delay.

show abstract

Standard expected years of life lost (SEYLL) due to chronic obstructive pulmonary disease (COPD) in Poland from 1999 to 2014

Cited by 8 publications

References 38 publications

Economic Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer Between 2000 and 2015 in Saskatchewan: Study Protocol

Economic Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer Between 2000 and 2015 in Saskatchewan: Study Protocol

The global burden of premature mortality due to the Middle East respiratory syndrome (MERS) using standard expected years of life lost, 2012 to 2019

Analysis of Medical Seeking Behavior and Influencing Factors in Patients With Chronic Obstructive Pulmonary Disease

Contact Info

Product

Resources

About